Denne indikation kan derfor ikke accepteres.
very high Left Ventricular Hypertrophy The CHMP concluded that the indication for the initial therapy of hypertension with the fixed dose combination (FDC) does not have a positive benefit-risk ratio, and therefore is not acceptable.